VERÖFFENTLICHUNGEN
PUBLIKATIONEN
Schmitt A, Barth TF, Beyer E, Borchert F, Rojewski M, Chen J, Guillaume P, Gronau S, Greiner J, Möller P, Riechelmann H, Schmitt M (2009) The tumor antigens RHAMM and G250/CAIX are expressed in head and neck squamous cell carcinomas and elicit specific CD8+ T cell responses, Int J Oncol. Mar;34(3):629-39.
Riechelmann H, Sauter A, Golze W, Hanft G, Schroen C, Hoermann K, Erhardt T, Gronau S. (2008) Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma. Oral Oncol. Jan 44(9):823-917.
Riechelmann H, Wiesneth M, Schauwecker P, Reinhardt P, Gronau S, Schmitt A, Schroen C, Atz J, Schmitt M. (2007) Adoptive therapy of head and neck squamous cell carcinoma with antibody coated immune cells: a pilot clinical trial. Cancer Immunol Immunother. 2007 Sep;56(9):1397-406.
Sauter A, Kloft C, Gronau S, Bogeschdorfer F, Erhardt T, Golze W, Schroen C, Staab A, Riechelmann H, Hoermann K. (2007) Pharmacokinetics, immunogenicity and safety of bivatuzumab mertansine, a novel CD44v6-targeting immunoconjugate, in patients with squamous cell carcinoma of the head and neck. Int J Oncol. Apr;30(4):927-35.
Gronau S, Thess B, Riechelmann H, Schmitt M (2006) An autologous system for culturing Squamous Cell Carcinomas as a nearly in-vivo-model on the Chorioallantois-Membrane. European Archieves of Oto-Rhino-Laryngology and Head and Neck Apr;263(4):308-12.
Fischer Y, Neagos A, Gronau S, Rettinger G (2006) Variabilität klinischer Befunde bei Patienten mit schlafbezogenen Atmungsstörungen (SBAS) in Abhängigkeit vom Untersucher. Laryngo-Rhino-Otologie May;85(5):338-43.
Riechelmann H., Neagos A. , Netzer U., Gronau S, Scheithauer M., Rockemann M. (2006) Der ASA-Score als Komorbiditätsindex bei Mundhöhlen- und Mundrachenkarzinomen Laryngo-Rhino-Otologie Feb;85(2):99-104.
Gronau S, Schmitt M, Reinhardt P, Wiesneth M, Riechelmann H (2005) Removabâ aktivierte Lymphozyten bei Plattenepithelkarzinomen des oberen Aerodigestivtraktes. Laryngorhinootologie 85(2) Nov;84(11):822-8.
Rozsasi A, Kuhnemann S, Gronau S, Keck T. (2005) A single-center 6-year experience with two types of pediatric tracheostomy. Int J Pediatr Otorhinolaryngol. 69(5):607-13.
Gronau S, Schmitt M, Reinhardt P, Wiesneth M, Riechelmann H. (2005) Trifunctional bispecific antibody-induced tumor cell lysis of squamous cell carcinomas of the upper aerodigestive tract. Head Neck. 27(5):376-82.
F. Bogeschdorfer, Gronau S, H. Riechelmann (2005) Neue Therapien bei Kopf-Hals-Tumoren. Laryngo-Rhino-Otologie, Jul;85(7):520-9.
Fischer Y, Gronau S. (2005) Identifikation und Evaluation der kindlichen Schlafapnoe vor Adeno-tonsillektomie anhand evaluierter Fragebögen. Laryngorhinootologie. 2: 121-135.
Gronau S, Fischer Y. (2005) Die Tonsillotomie. Laryngorhinootologie. 84(2):121-35
Riechelmann H, Deutschle T, Stuhlmiller A, Gronau S, Burner H (2004) Nasal toxicity of benzalkonium chloride. Am J Rhinol. 18(5):291-9.
Schmitt M, Schmitt A, Reinhardt P, Thess B, Manfras B, Lindhofer H, Riechelmann H, Wiesneth M, Gronau S. (2004) Opsonization with a trifunctional bispecific (alphaCD3 x alphaEpCAM) antibody results in efficient lysis in vitro and in vivo of EpCAM positive tumor cells by cytotoxic T lymphocytes. Int J Oncol. 25(4):841-8.
Koenig-Greger D, Riechelmann H, Wittich U, Gronau S (2004) Genotype and phenotype of glutathione-S-Transferase in patients with head and neck carcinoma. Otolaryngol-Head-Neck-Surg. 130(6): 718-25.
Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. (2003) Gene polymorphisms in detoxification enzymes as susceptibility factor for head and neck cancer? Otolaryngol-Head-Neck-Surg. 128(5): 674-80.
Gronau S, Menz C.K, Melzner I, Hautmann R, Moller P, Barth T.F. (2002) Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder. Virchows-Arch. 440(4): 436-40.
Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. (2003) GSTM1 enzyme concentration and enzyme activity in correlation to the genotype of detoxification enzymes in squamous cell carcinoma of the oral cavity. Oral-Dis. 9(2): 62-7.
Gronau S, Koenig-Greger D, Jerg M, Riechelmann H. (2002) 11Beta-hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck. Clin-Otolaryngol. 27(6): 453-7.
Gronau S, Konig-Greger D, Rettinger G, Riechelmann H. (2000) GSTM1-Genpolymorphismus bei Patienten mit Kopf-Hals-Tumoren. Laryngorhinootologie. 79(6): 341-4.
Rother T, Riechelmann H, Gronau S. (2005) Sekundär beschleunigte Fremdkörper als Gefahrenquelle bei Airbagauslösung. HNO Dec;54(12):967-70.
Wiesmiller K, Barth T.F, Gronau S. (2004) Early radiation-induced malignant fibrous histiocytoma of the oral cavity. J-Laryngol-Otol. 117(3): 224-6.
Menges T, Kostrezewa M, LWelters, Little SG, Wagner RM, Gronau S, Mueller U, Hempelmann G (1997) Association of bi-allelic NCOI polymorphism within the tumor necrosis factor locus with the prognosis and outcome of severely injured trauma patients. In Faist E (Editor) 4th International congress on the Immune Consequences of Trauma, Shock and Sepsis – Mechanisms and Therapeutic Approaches. Monduzzi Editore, Bolonga, 811-815.